Design, synthesis and biological evaluation of brain-specific glucosyl thiamine disulfide prodrugs of naproxen

Eur J Med Chem. 2011 Sep;46(9):3651-61. doi: 10.1016/j.ejmech.2011.05.029. Epub 2011 May 20.

Abstract

Glucosyl derivates exhibited favorable distribution to the brain. However, bidirectional transport of glucose transporter 1 might decrease concentrations of the prodrugs in brain before the release of parent drugs. To overcome this defect, glucosyl thiamine disulfide prodrugs 1a-1c incorporating naproxen were designed and synthesized. Furthermore, prodrug 2 and 3 were also prepared as control. The favorable physicochemical properties of these prodrugs were verified by stability and metabolism studies. Results from the in vivo distribution study indicated that 1a-1c, and 1b in particular, significantly increased the level of naproxen in brain when compared to 2 and 3. The study suggested glucosyl thiamine disulfide was a promising carrier to enhance the brain bioavailability of central nervous system active drugs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacokinetics
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Biological Availability
  • Blood-Brain Barrier
  • Brain / drug effects*
  • Chromatography, High Pressure Liquid
  • Disulfides / chemistry*
  • Drug Design*
  • Glucosides / chemistry*
  • Magnetic Resonance Spectroscopy
  • Mass Spectrometry
  • Mice
  • Naproxen / analogs & derivatives*
  • Naproxen / chemistry
  • Naproxen / pharmacokinetics
  • Naproxen / pharmacology*
  • Prodrugs / pharmacokinetics
  • Prodrugs / pharmacology*
  • Tissue Distribution

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Disulfides
  • Glucosides
  • Prodrugs
  • Naproxen